The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development
about
YC-1 induces G0/G1 phase arrest and mitochondria-dependent apoptosis in cisplatin-resistant human oral cancer CAR cellsBenzimidazole analogs as potent hypoxia inducible factor inhibitors: synthesis, biological evaluation, and profiling drug-like propertiesVascular endothelial growth factor: An important molecular target of curcumin.A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts.Progesterone in Breast Cancer Angiogenesis
P2860
The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The anticancer agent YC-1 supp ...... rests breast tumor development
@ast
The anticancer agent YC-1 supp ...... rests breast tumor development
@en
type
label
The anticancer agent YC-1 supp ...... rests breast tumor development
@ast
The anticancer agent YC-1 supp ...... rests breast tumor development
@en
prefLabel
The anticancer agent YC-1 supp ...... rests breast tumor development
@ast
The anticancer agent YC-1 supp ...... rests breast tumor development
@en
P2093
P2860
P356
P1476
The anticancer agent YC-1 supp ...... rests breast tumor development
@en
P2093
Candace E Carroll
Cynthia Besch-Williford
Indira Benakanakere
Salman M Hyder
Yayun Liang
P2860
P304
P356
10.3892/IJO.2012.1675
P577
2012-10-24T00:00:00Z